SURVIVAL ANALYSIS OF NASOPHARYNGEAL CARCINOMA  IN HASAN SADIKIN HOSPITAL by Adriana , Riska et al.
International Journal of Nasopharyngeal Carcinoma (IJNPC) Vol. 01, No. 01, 2019 | 03-06 
 
International Journal of  
NASOPHARYNGEAL CARCINOMA 
 
 
Journal homepage: ijnpc.usu.ac.id 
 
 
Copyright © International Journal of Nasopharyngeal Carcinoma, Published by Talenta Publisher, ISSN: 2656-9027 e-ISSN: 2656-9035, DOI: 10.32734/ijnpc.v1i1.952 
 
 
03 
SURVIVAL ANALYSIS OF NASOPHARYNGEAL CARCINOMA  
IN HASAN SADIKIN HOSPITAL 
Riska Adriana1, Yussy Afriani Dewi2, Dindy Samiadi2, Edo Wira Candra3*  
1Hermina Arcamanik Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Jawa Barat, Indonesia 
2Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Padjadjaran University, Bandung, Jawa Barat, Indonesia  
3EMC Sentul City Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Jawa Barat, Indonesia 
Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is the fifth in range of malignancies in Indonesia and has high 
morbidity and mortality. A survival rate is a statistical index that summarizes the probable frequency of specific 
outcomes for a group of patients at a particular point in time. The survival of patients with nasopharyngeal 
carcinoma is influenced by several factors, such as the patient and tumor.  
Objective: The objective of this research is to determine survival analysis and factors that influence 
nasopharyngeal carcinoma which recorded at Hasan Sadikin Hospital.  
Methods: It is an analytic observational study. Data were analyzed with survival analysis using the Cox Regression test.  
Result: The subjects were 215 patients who were diagnosed NPC in first time at Hasan Sadikin Hospital from 
January 2006 until December 2009. There was a significant correlation between age, staging, histopathologic 
type and therapy with the survival (p=0.0001), (p=0.026), (p=0.0001), (p=0.024), (p=0.003); but no significant 
correlation between gender with the survival. Based on Cox proportional hazard, the male patients in over fifty 
years old have a risk of the death 7.724 and 1.113 times. The patients with nasopharyngeal carcinoma type I 
have a risk of the death 2.381 times. The patients with stage IVC have a risk of the death 3183.9 times. The 
patients who underwent chemoradiation have a risk of the death 2.761 times.  
Conclusion: The survival of patients with nasopharyngeal carcinoma is most influenced by prognostic factors 
such as age and therapy. 
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1. INTRODUCTION 
Nasopharyngeal carcinoma is a malignant tumor originating from the 
epithelium nasopharynx with the most common predilection in the 
Rosenmuller fossa. Nasopharyngeal carcinoma occurs due to interactions 
between genetic factors, Epstein Barr virus infection (EBV), environmental 
factors such as exposure to carcinogenic substances, smoke, and foods 
which contain nitrosamines such as salted fish [1]. 
Nasopharyngeal carcinoma ranks 23rd of all malignancies in the world, 
the fifth of all malignancies in Indonesia, and is ranked first in head and 
neck malignancies division. The incidence of NPC in Indonesia reached 4.7 
per 100,000 population per year, the highest in the decade 4-5 with a 
comparison between men and women, 2-3:1. Prevalence at ORL-HNS 
Department in Dr. Hasan Sadikin Bandung Hospital during 2006-2010 
period is 41.7% [1-3]. 
Nasopharyngeal carcinoma is hard to diagnose early because of its location. 
A patient often does not immediately come for treatment. Symptoms of NPC 
associated with the location of the primary tumor, infiltration of the tumor into 
the surrounding structure of nasopharynx, or lymph node metastasis. Mass in the 
nasopharynx can cause nasal symptoms such as nasal congestion and runny nose. 
Tumor ulceration will cause epistaxis. Ear symptom arises from expansion of the 
mass around the eustachian tube which causes fluid arises in the middle ear, 
unilateral conductive deafness, otalgia, and tinnitus. Serous otitis media was 
found in 41% of 237 patients diagnosed with NPC. Tumor growth can extend to 
the skull cavity through the lacerum foramen which affects the anterior group and 
posterior group which results in cranial nerve abnormalities [1]. Tumor 
metastasis to neck lymph nodes can occur unilateral or bilateral. Enlargement of 
the neck often occur (60%-97.5%) and is the main reason people come to doctor. 
The retrospective study by Aribas et al. in 2008 shows that the lymphadenopathy 
found in 76% patients, nasal symptoms in 73%, ear symptoms in 62% patients, 
and cranial nerve disorders in 20% patients [1, 4, 5]. 
Nasopharyngeal carcinoma has high morbidity and mortality despite the 
modality of treatment [5]. Data in the United Kingdom in 2014, shows that the 
five-year survival rate in stage I, stage II, stage III, and stage IV in 
chronological order are 80%, 65%, 60%, and 50%. Whereas data statistics in 
America in 2014, shows that the five-year survival rate in stage I, stage II, stage 
III, and stage IV in chronological order is 72%, 64%, 62%, and 38% [6]. 
A survival rate of NPC depends on several factors, such as the 
aggressiveness of tumor cells based on tumor expansion, expansion to collie 
lymph nodes, and distant metastasis, as well as patient characteristics, age, 
race, and gender. Other factors also influence the prognosis, such as NPC 
histopathology classification based on the World Health Organization 
(WHO), and therapeutic intervention in NPC patients [4]. A study by Lee et 
al. in Taiwan in 2011 found that factors affecting the survival rate of NPC 
are socioeconomic, geographical location, hospital facilities, and clinical 
stages of the NPC [7]. El-Sherbieny in Kuala Lumpur showed that NPC 
stage and histopathological features could be affecting survival rate. Non-
keratinized squamous cell carcinoma (SCC) and undifferentiated carcinoma 
had a higher survival rate compared with keratinized squamous cell carcinoma [8].  
A study in Brazil in 2003 showed that patient's age, clinical stage, 
histopathology, and therapy could affect the survival rate. Despite that 
nasopharyngeal carcinoma is a radiosensitive tumor, at the advanced stage 
the response is decreasing. A study in Brazil showed that patients with stage 
III NPC in Brazil had a five-year survival rate of 28% and stage IV around 
35% [9]. The survival rate is the percentage of individuals who survive 
certain diseases, in this case, is NPC, for a specified amount of time [10]. 
Medical studies often use the overall survival in assessing the effectiveness 
of the therapy that can affect prognosis and survival rate [11]. Patient 
condition and tumor factors influence the survival rate of the NPC.               
The survival rate is analyzed with a specific design using survival analysis. 
Survival analysis is described as a set of statistical procedures using an 
analytical method to analyze variables, which outcome is time until the 
occurrence of specific events, such as death, disease recurrence, or recovery. 
Time can be measured by year, month, day, hour, or a minute from the observation 
until the events [12, 13].Survival rate and factors that affect patients with 
nasopharyngeal carcinoma at Hasan Sadikin Hospital Bandung never been 
studied. Based on these considerations, this research was conducted. 
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2. MATERIAL AND METHODS 
This study is an analytic observational study with a special design of 
survival analysis. Data were collected retrospectively from medical records. 
The subjects of the study were patients diagnosed with NPC in the period 
January 2006 until December 200 in the ORL-HNS Department at the Dr. 
Hasan Sadikin Bandung Hospital and met the inclusion criteria.  
Data were collected from medical records, such as age, sex, race, 
education, occupation, socioeconomics, clinical stage, histopathology, 
therapy, and patient response. Then the patient or family is contacted by the 
researcher to find out whether the patient is alive or dead. Data were 
analyzed with survival analysis using the Cox Regression test. 
3. RESULT 
The number of sample data obtained is 215 which are included in the 
inclusion and exclusion criteria. 
Table 1. Life Table of NPC 
Time (years) 
Number of death 
(%) 
Mean 
Survival Rate (%) SE 
1 11 86.9 0.02 
2 49 52.9 0.02 
3 72 3.0 0.02 
4 84 33.2 0.02 
5 90 30.9 0.02 
note: 
SE: standard error    
 
Table 1 is a cumulative life table of NPC patients in the first to the fifth 
year. In the first year, subjects who died is 11% and those who survive is 
86.9%. In the second year, the subject who died became 49% and those who 
survive is 52.9%. In the third year, subjects who died increased by 72% and 
those who survive decreased to 38.9%. In the fourth year subjects who died 
became 84% and those who survive were 33.2%. In the fifth year, subjects 
who died is 90% and those who survive is 30.9 %. 
Table 2. Survival Rate 
Prognostic Factors Total Percentage Survival Rate 
 (n=215) (%) (%) 
Age    
< 20 years 5.0 2.3            76.1 
20-29 years 14.0 6.5              9.2 
30-39 years 34.0 15.8            11.8 
40-49 years 77.0 35.9              2.9 
>50 years 85.0 39.5                 0 
Sex    
Man 148.0 68.8            32.3 
Woman 67.0 31.2            67.7 
Race    
Deutro Malay 192.0 89.3            89.2 
Malay 12.0 5.6              4.6 
Mongoloid 11.0 5.1              6.2 
Occupation    
Government Employee 20.0 9.3             4.6 
Private Employee 108.0 50.2             2.9 
Labor/ maid 82.0 38.2           28.7 
Student 5.0 2.3           53.8 
Level of Education    
Primary school 100.0 46.5           15.4 
Junior high school 28.0 13           24.6 
High school 45.0 21           29.2 
College 42.0 19.5           30.8 
Socioeconomics    
Very low income 30.0 14.0            9.2 
Low Income 79.0 36.8          29.2 
Medium Income 52.0 24.2          27.7 
Standard Income 54.0 25.0          33.8 
Histopathology    
WHO Type I 10.0 4.6               0 
WHO Type II 22.0 10.2            6.2 
WHO Type III 183.0 85.2          93.8 
Clinical Stage    
Stage I 1.0 0.5          44.6 
Stage II 25.0 11.6          24.6 
Stage III 58.0.0 27.0          15.4 
Stage IVA 41.0 19.1          13.8 
Stage IVB 84.0 39.0            1.5 
Stage IVC 6.0 2,8               0 
Therapy    
Radiotherapy 25.0 11.6           23.1 
Chemoradiation 190.0 88.4           76.9 
Response    
Complete 213.0 99.0        100.0 
Residing 1.0 0.5                0 
Recurrent 1.0 0.5                0 
Based on age distribution, NPC patient was dominant in the age group 
for more than 50 years (89 people). The survival rate for the age group less 
than 20 years, 20-29 years, 30-39 years, 40-49 years and more than 50 years, 
respectively is 76.1%; 9.2%; 11.8%; 2.9%; 0%. Men are more common than 
women (68.8% vs. 31.2%). The overall survival rate for men and women is 32.3% 
and 67.7%. According to race distribution, Deutro Malay is more common than 
Malay and Mongoloid, with the survival rate is 89.2; 4,6%; and 6.2%. 
Based on occupation, most NPC patients were private employees (108 
people/50.2%). The overall survival rate for government employees, private 
employees, labor/ maid, and students are 4.6%; 2.9%; 28.7%; 53.8%. Most 
NPC patients had a low level of education, equivalent to Primary School 
(46.5%). The survival rate for elementary school-graduates, Junior High 
School graduates, High School Graduates, and University graduates are 
24.6%; 15.4%; 29.2%; 30.8%. Low income patients were common (36.8%) 
with survival rate for very low income, low income patient, middle income, 
and standard income patients are 9.2%; 29.2%; 27.7%; 33.8%. 
The most common carcinoma were type 3 WHO or undifferentiated 
carcinoma (85.2%), with survival rate for type 1, 2, and 3 are each 0%; 6.2%; 
93.8%. Based on the clinical stage, the most patient was diagnosed in stage IV 
(39%). Survival rate for stage I, II, III, IVA, IVB, and IVC are 44.6%; 24.6%; 
15.4%; 13.8%; 1.5%; and 0%. Combination therapy of radiotherapy and 
chemotherapy is the most common management (88.4%). The overall survival 
rate for radiotherapy and chemotherapy are 23.1% and 76.9%. Most NPC 
patients had a complete response (99%) with a 100% survival rate. 
The results of the statistical analysis for the hazard ratio is shown in 
table 3. Patient's age, level of education, histopathology of the tumor, 
clinical stage, and therapy were significant (p-value <0.05). Age above 50 
years have a poorer survival rate among another age group, with the hazard 
ratio 7.724 meaning that patients older than 50 years old were 7.724 times 
more likely to die. Based on the histopathology, the data showed that WHO 
type 1 nasopharyngeal carcinoma had the most higher hazard ratio than type 
2 or 3. Based on the clinical stage of the tumor, we found that patient with 
the IV C clinical stage were 3183.926 times more likely to die. Patient 
undergoing radiotherapy had better survival than chemoradiation. Based on 
the hazard ratio, chemoradiation therapy had a value of 2.761 which 
indicates that at any time, death was more likely to happen than in patients 
undergoing radiotherapy. 
Table 3. Bivariate Analysis of Hazard Ratios Based on Alive and Death Category 
Variable 
Hazard Ratio 
P value 
B value Exp. B 
Age    
<20 years   0.0001 
20-29 years 0.692 1.998  
30-39 years 0.834 2.303  
40-49 years 1.511 4.529  
>50 years 2.044 7.724  
Sex    
Man 0.107 1.113 0.545 
Woman    
Race    
Deutro Malay 0.161 1.174 0.701 
Malay 0.405 1.500  
Mongoloid    
Occupation    
Government employee 1.949 7.020 0.160 
Private Employee 1.515 4.548  
Labor/maid 1.531 4.622  
Student    
Education    
    Primary School 0.399 1.491 0.026 
    Junior High School -0.062 .940  
     High School -0.195 .823   
     College     
Socioeconomics     
     Very low income 0.290 1.336 0.688  
     Low income 0.122 1.129   
 Medium Income 0.016 1.017   
 Standard Income     
Histopathology     
 WHO type I 0.868 2.381 0.024  
 WHO type II 0.261 1.298   
 WHO type III     
Clinical Stage     
 Stage I   0.0001  
 Stage II 6.231 508.216   
 Stage III 6.589 727.248   
 Stage IVA 7.302 1483.919   
 Stage IVB 7.781 2393.697   
 Stage IVC 8.066 3183.926   
Therapy     
 Radiotherapy   0.003  
 Chemoradiation 1.016 2.761   
Response     
 Recurrent -2.517 0.081 0.111  
 Residing 1.965 7.137   
 Complete     
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Table 4. Multivariate analysis between independent variables and survival rate 
 
Variable Hazard Ratio 
CI 95% 
       P value 
 Upper Level Lower Level 
 <20 years  old    0.000 
 20-29 2.414 0.282 20.694 0.421 
 30-39 2.587 0.340 19.688 0.359 
 40-59 4.980 0.688 36.059 0.112 
 >50 8.788 1.218 63.395 0.031 
 Therapy 2.850 1.448 5.610 0.002 
 
Multivariate analysis was done to assess the magnitude of the 
relationship between variables with a 5-year survival where the p-value is 
less than 0.05 (p <0.05). In the next step, multivariate analysis will see the 
effect of each variable by looking at the hazard ratio. Based on this analysis, 
variables that had the most influence on the survival rate of NPC patients 
based on the hazard ratios are the patient's age and therapy, with 95% CI. 
4. DISCUSSION 
Table 2 explains the variable age of the dominant patient is the age group of 
more than 50 years, which is as many as 89 people. The same results were 
reported by Putri in Bandung regarding the characteristics of patients with 
nasopharyngeal carcinoma in the ORL-HNS Department of Padjadjaran 
University, Hassan Sadikin Central Hospital in the period 2006-2010 that had a 
higher incidence of NPC at the age of 50-59 years. Research conducted by Heng 
et al. Reported the highest prevalence of NPC at the age of 40-59 years [14]. All 
of these studies showed the first exposure to carcinogenic substances until the 
onset of cancer takes a long time [2, 3]. The most commonly histopathological 
type found is WHO type III, which is undifferentiated carcinoma as many as 183 
people (85.2%) compared to WHO types I and II. These results are in accordance 
with Adham et al., Who reported that WHO type III was found to be around 85% 
while WHO type II was found to be 2.3% [2]. The El-Sherbieny study et al. 
Reported that WHO type III was more dominant than WHO type II, each of 
which was 106 people (67%) and 53 people (33%). Research Xiao et al got the 
highest WHO type III results compared to WHO types I and II, each of which 
amounted to 185 people (86.9%), 25 people (11.7%), 3 people (1.4%) [15]. All 
of these studies were due to WHO type III in Southeast Asia and in other 
countries with a high incidence of NPC, besides of that undifferentiated 
carcinoma have a strong correlation with EBV and found high p53 gene 
expression that correlated with high tumor cell proliferation [2, 16, 17].  
Most of the patients with NPC in this study were given combination therapy 
of radiotherapy and chemotherapy, namely 190 people (88.4%), and from the 
overall therapy that received a complete response of 213 people (99%). Aribas et 
al. 'S study, reported that there were about 175 people with NPC treated by 
combination radiotherapy and chemotherapy compared to radiotherapy alone, 
who received a complete response are 217 people [4]. Al-Sarraf reported that 
treatment of NPC with a combination of radiotherapy and chemotherapy resulted 
in 89% complete responses. This is because NPC is chemosensitive and 
radiosensitive. Tumor cell Radiosensitivity depend on several factors, namely 
cell differentiation and cell proliferation cycles that are known to have a role in 
influencing the effects of radiation on cells in phases Gap 2 (G2) and mitosis (M) 
[4, 9, 18]. The success of chemotherapy depends on the size of the tumor and the 
percentage of tumor cells responsive to chemotherapy [1, 5, 19]. 
Table 3 explains the relationship between age and survival using a statistical 
test known p-value of 0.0001 (p-value <0.05). This shows that there is a 
statistically significant relationship between age category variables and survival, 
based on life and death groups. At the age above 50 years have worse survival 
compared to other age categories. The value of the hazard ratio is 7.724 shows 
that every time death is faster in the age category above 50 years. This result is 
similar to Burt et al. Study who reported that age was an independent variable 
that significantly affected survival, where the value of p <0.001. Ou et al studied 
2.436 NPC patients with results that at a younger age had a better survival 
statistically p-value <0.0001 [18].  All the results of the study were due to age 
associated with the carcinogenesis process which consists of several mechanisms 
namely the accumulation of cells within tissue in the process of carcinogenesis 
occurs at an advanced stage and changes in hemostasis, immune system and 
endocrine can occur. Old age can be accompanied by comorbidities such as 
diabetes, hypertension, myocardial infarction which can worsen the general 
condition so that it affects the therapy to be carried out and tends to worsen 
conditions due to therapy for example nephrotoxicity, myelosuppression, 
electrolyte disorders, diarrhea, nausea and vomiting [7, 15, 20]. 
Table 3 explains the relationship between education and survival using 
statistical tests. It is known that the p-value is 0.026 (p-value <0.05). This 
shows that there is a statistically significant relationship between education 
variables on survival based on life and death groups. Higher education has 
better survival. The highest hazard ratio in the elementary education 
category is 1.491 times which indicates that at any time the death is faster 
in the elementary education group. The same results as Putri's research 
showed that the highest level of education for NPC patients was 259 
elementary school students (52.5%) so that due to low levels of 
intellectuality the patients did not know the early symptoms of NPC, so there 
was a delay in treatment [3]. 
The association of histopathological type with survival using statistical 
tests is known to have a p-value of 0.024 (p-value <0.05). This shows that there 
is a statistically significant relationship between histopathological variables on 
survival based on life and death groups. WHO type I has the highest hazard 
ratio value of 2.381 which indicates that WHO type I every time of death is 
faster than WHO type III. The same study results of Thompson et al. that 
keratinized squamous cell carcinoma has a worse survival (20%-40%) 
compared to undifferentiated carcinoma (65%). Reddy et al. reported that 
WHO type I significantly affected the 5 years survival (p-value=0.001).            
Hsu et al. reported 78 cases of NPC with WHO type I had worse survival than 
WHO types II and III. (p-value <0.0000) [21]. This is due to keratinized 
squamous cell carcinoma has a large tendency in local growth of the tumor, is 
not closely related to EBV infection, and is less radiosensitive [1, 2]. 
In table 3 it can be seen the relationship between the stage of the disease 
with survival using a statistical test with a p-value of 0.0001 (p-value <0.05). 
This shows that there is a statistically significant relationship between the 
stadium variables on survival based on life and death groups. In stage I, have 
better survival. These results are in accordance with Farius et al. study, 
reporting 5-year survival in stage I was better than stage II, III and IV, which 
was 100% [9]. Liu et al. get the results of stage I and II having a 3-year 
survival better than stage III and IV. This is because the possibility of 
metastasis in patients with NPC with an early stage is very low [22]. 
Research Chua et al., Who reported stage I had a better 10-year survival of 
98% [23]. Based on the value of the hazard ratio, stage IVC had the highest 
value of 3183.926 times where at any time death was faster in stage IVC. 
Clinical research according to Kong says the clinical stage of NPC is related 
to prognosis. People with NPC with stage IVC where the tumor has 
metastasized has a survival of less than 10% [24]. 
The therapy given has a relationship with survival through a statistical 
test with a p-value of 0.003 (p-value <0.05). This shows that there is a 
statistically significant relationship between therapeutic variables on 
survival based on life and death groups. In NPC patients, radiotherapy has 
better survival than chemoradiation. Kong et al. Reported a 5-year survival 
of NPC patients with radiotherapy reaching 50%-80%[24]. Chua et al.              
Study reported 141 people in stages I and II had very good results, 10-year 
survival reached 98% [23]. Based on the hazard ratio combination between 
radiotherapy and chemotherapy have a value of 2,761 times which indicates 
that at any time death is faster than in patients with radiotherapy therapy. 
Therapy on NPC is given in order to reduce tumor progression. Therapy is 
also closely related to stage. Radiotherapy is a therapeutic modality for NPC 
at an early stage, while combination therapy for radiotherapy and 
chemotherapy is given at an advanced stage. The results of therapy will be 
bad if the primary tumor is large, infiltrative, ulcerative, extended to the 
intracranial, large neck tumor, and distant metastasis. So that it can be 
concluded that survival in patients with NPC with combination therapy of 
radiotherapy and chemotherapy will be worse than radiotherapy [1, 24, 25]. 
Based on the multivariate analysis in table 4, it can be explained that 
the variables that most influence the survival of NPC patients based on p values 
<0.05 and the order of strength of hazard ratios are age and therapy categories. 
In this study there are limitations, that is data from the medical record 
have no shown comorbidities in NPC patients who can aggravate general 
conditions such as diabetes, hypertension, myocardial infarction. Another 
limitation is the absence of nutritional medical record data on NPC patients 
who can have an impact on increasing morbidity and mortality [26, 27]. 
5. CONCLUSION 
The characteristics of NPC patients who are the subjects of the study are 
more commonly found in men and over 50 years of age. The most dominant 
Patients with NPC are Malay deutro race. Most types of work distribution are 
private employees. The highest level of education for NPC patients is an 
elementary school. The low-income socioeconomic group is the dominant 
variable. The most histopathological type is the WHO type III NPC. The most 
common therapy is a combination therapy of radiotherapy and chemotherapy. 
The survival of NPC patients is influenced by prognostic factors, namely age, 
sex, education, histopathology type, clinical stage, and therapy. 
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